Dr Swarup’s AWARDS & HONORS:
• 3rd Place – American Medical Association, Eastern Student Research Forum (1990) • 2nd Place – Howard University, Medical Research Competition (1990) • 2nd Place – Ophthalmology Residents Day Symposium, Howard University Hospital (1990) • Who’s Who of Students in U.S.A. (1989 – 1990) • Academic Scholarship (1987 – 1991) • James Mitchell Foundation Scholarship Surgery Fellowship (1989) • Beta Kappa Chi Science Honor Society • Golden Key National Honor Society • Dean’s List ( 1985 – 1986)

PROFESSIONAL AFFILIATIONS:

• American Academy of Ophthalmology • North Carolina Medical Society • Pasquotank, Camden, Currituck, and Dare County Medical Society • American Society of Cataract and Refractive Surgery • Board Certified with American Board of Ophthalmology (Since 1987)

CLINICAL TRIAL EXPERIENCE:

2013 – Present Medical Director Albemarle Clinical Trials, LLC

1989 – 1991 Research Assistant Howard University Hospital Department of Ophthalmology

1989 – 1991 Research Assistant James Mitchell Foundation Surgery Fellowship Howard University Hospital Department of Cardiothoracic and Vascular Surgery 1988 – 1988 Research Assistant National Institutes of Health Department of Neuropharmacology

1985 – 1986 Research Assistant Howard University Cancer Center Department of Oncology

1984 – 1985 Research Assistant Howard University College of Medicine Department of Anatomy

CLINICAL TRAIL COURSES:

May 29, 2017 CITI Collaborative Institutional Training Initiative Good Clinical Practices Training

May 28, 2015 CITI Collaborative Institutional Training Initiative Good Clinical Practices Training

April 26–27, 2013 Foundations of Clinical Research Seminar by Alcon

October 31, 2012 National Institute of Health Good Clinical Practices Training

October 29, 2012 CITI Collaborative Institutional Training Initiative Institutional Review Board Training

PRINCIPAL INVESTIGATOR ON THE FOLLOWING CLINICAL TRIALS:

A Comparison of ********* ** to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension November 2016 – Present

Qualitative Development of a Treatment Satisfaction Measure in Glaucoma or Ocular Hypertension September 2016 – Present

A prospective, multi-center, randomized, double-masked, positive-controlled phase 3 clinical trial designed to evaluate the safety and efficacy of ********** ********** ********** ophthalmic solution compared to ********* ********** ophthalmic suspension (*%) in patients with non-infectious anterior segment uveitis March 2016 – Present

The Efficacy and Safety of ********* ** in Patients with Open-Angle Glaucoma or Ocular Hypertension September 2014 – August 2015

A Prospective, Randomized, Controlled, parallel groups, Multicenter clinical investigation of the ********** Trabecular Micro-Bypass Stent System ********* ****** vs. Selective laser trabeculoplasty August 2014 – August 2015

A Multicenter, Randomized Double-Masked Vehicle-Controlled, Parallel Group Phase III Study of the Efficacy and Safety of Single Sub-conjunctiva Injections of ***** for the Reduction of Post-Cataract Surgery Intraocular Inflammation July 2014 – September 2015

Post Approval Study of the ******* ** Toric High Cylinder Power IOL Models *****

July 2014 – December 2015

A Phase 3, Multi-Center, Double Masked, Vehicle-Controlled, Randomized, Parallel-Group Study to Assess ************ ******** Ophthalmic Gel, *.**% versus Vehicle Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery August 2014 – April 2015

A Multicenter, Randomized Dose-Ranging, Double-Masked, Placebo-Controlled Phase 2 Study Evaluating the Safety and Efficacy of **** Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain following the Ocular Surgery February 2014 – October 2014

A Prospective, Randomized, Controlled, parallel Groups, Multicenter Post-Approval Study of the ********* Trabecular Micro-Bypass Stent System in Conjunction with Cataract Surgery July 2013 – Present

Randomized, Double-Masked, Vehicle Controlled, Clinical Evaluation to Assess the Safety and Efficacy of ***** Ophthalmic Suspension, *.*% for Improvement in Clinical Outcomes among Diabetic Subjects Following Cataract Surgery July 2015 – August 2015